Inflammation was reported as a recurrent pathological feature observed in patients with the RNF213 Arg4810Lys mutation and pulmonary hypertension [1,160,161,162,163,164,165,166,167,168,169,170]. This evidence concerns the gene RNF213 and pulmonary arterial hypertension.